Symptomatic burden in myelofibrosis (MF): Prospective international assessment in 128 MF patients.R. Scherber, Ruben A. Mesa, Giovanni Barosi et al.|Journal of Clinical Oncology|2011Cited by 4
Development of an MF patient reported outcome (PRO) tool for FDA qualification: Comprehensive literature search and physician cognitive debriefing resultsHolly L. Geyer, Rosa María Alonso Mesa, Heidi Kosiorek et al.|Unknown|2016Cited by 0